Predictmedix Inc.

Predictmedix Inc.

Predictmedix Inc. is a Canadian health technology company that has focused on building AI-driven diagnostic systems, particularly for screening impairment and infectious disease through contactless multispectral imaging. The firm is publicly traded and has sought to commercialize its technology across workplace, transit, and healthcare settings. It targets sectors with a need for rapid, non-invasive health checks. The company's core product, the SafeGait platform, is designed to detect impairment from alcohol or cannabis, and its Multispectral Imaging Solution screens for elevated body temperature and other signs of infectious illness. These tools are marketed to employers, event venues, and transportation authorities. The firm has announced partnerships and pilot programs in Canada and internationally, though geographic reach remains modest. As a publicly listed entity, Predictmedix reports through regulatory filings, but specific metrics on deployment, AUM, or professional count are not part of its profile as a health tech developer rather than an asset manager. Its team composition and additional offices are not publicly documented in available sources. The structural differentiator for Predictmedix is its focus on non-contact health diagnostics using proprietary AI and multispectral imaging, a niche within the broader digital health space. The firm's public listing provides transparency through disclosure requirements, though its operational details are sparse in the public domain.